News

New data on the devices will be available at the 2024 American Academy of Dermatology Annual Meeting.

Among the many sessions to be held at the Winter Clinical Miami 2024 Conference in Miami Beach, Florida, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

Click here to answer our poll about the upcoming conference.

An analysis of popular self-tanners revealed that more than half of them contained at least 10 potential allergens, and some contained 20 or more.

A case report examined an incidence of storiform collagenoma, also known as sclerotic fibroma, associated with Cowden syndrome in a patient. This occurrence is considered rare.

Researchers noted that this study's findings are consistent with prior epidemiologic data.

Click here to answer our poll about the upcoming conference in Puerto Rico.

The FDA has also granted nemolizumab Priority Review for prurigo nodularis.

The resubmission follows the Complete Response Letter Citius received from the US FDA in July of 2023.

This week’s collection of the latest dermatologic studies covers the causal relationship between lipid-related metabolites and androgenic alopecia, contact allergens in self-tanning products, a retrospective cross-sectional analysis of vitiligo patients in Canada, and combining systemic anti-PD-1 treatment with adjuvant ablative fractional laser in a mouse model of cutaneous SCC.

Tapinarof cream demonstrated highly statistically significant improvement in the primary end point of vIGA-AD treatment success over vehicle at week 8.

Patients treated with the ointment showed improvement in lesional percentage body surface area.

In this week’s Pointers With Portela, the 208SkinDoc discusses the recent trend of tweens buying excessive skin care.

Artax announced that safety and efficacy data is expected in the second half of the year.

A recent study revealed improvements in sensitivity but highlighted disparities in diagnostic accuracy, particularly among non-specialists and in darker skin tones.

Alongside expert dermatologists, the NRS recently developed a Seal of Acceptance for skin care and cosmetic products clinically tested and evaluated for patients with rosacea.

Keep up with the latest headlines in dermatology from the past week, including biotech's potential role in alleviating symptoms of skin disease, new sun safety guidelines in Australia, and more.

The Skin Cancer Foundation’s initiative, Destination Healthy Skin, travels to various cities throughout the country in an RV, wherein volunteer dermatologists provide on-the-street, free-of-cost skin screenings.

Click here to answer this week’s acne poll.

ICYMI, this week we had news about Masterclasses in Dermatology, JNJ-2113's significant PASI and IGA responses for plaque psoriasis, Almirall's partnership with the Centre for Genomic Regulation, and more.

Shanna Miranti, MPAS, PA-C, shares updates on the status of roflumilast foam 0.3% and Cabtreo available in US pharmacies.

Both cream options were capable of reducing scores of itching, drying, burning, redness, and more.

Interim data from the clinical trial was presented in a poster at the South Beach Symposium, with itch reduction demonstrating immediacy and long-term capability.

For a patient with vitiligo who is concerned about potential flares, what might you recommend avoiding?

A discussion among roundtable participants revolved around the importance of effective communication, the impact of prolonged use of topical steroids, and the need for trust building in recommending novel treatment options.

Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.

Biologics represent the pinnacle of scientific progress, engineered to precisely target conditions previously deemed untreatable. However, any dermatology provider who has prescribed one quickly learns of the immense barriers surrounding them.

The partnership is focused on exploring innovative therapeutic strategies to address AD.

For the third consecutive year, physician assistants ranked number 2 behind nurse practitioners in the individual healthcare sector listing.

Krystal Biotech’s B-VEC was administered as an eyedrop for a patient with dystrophic epidermolysis bullosa with cicatrizing conjunctivitis.